Protocol of the TREASURE study: Thoracic RadiothErapy with Atezolizumab in Small cell lUng canceR Extensive disease – a randomized, open-label, multicenter phase II trial

被引：0
作者：
Farastuk Bozorgmehr
Petros Christopoulos
Inn Chung
Jelena Cvetkovic
Manuel Feißt
Johannes Krisam
Marc A. Schneider
Claus Peter Heußel
Michael Kreuter
Daniel W. Müller
Michael Thomas
Stefan Rieken
机构：
[1] Thoraxklinik at University Hospital of Heidelberg,Department of Thoracic Oncology
[2] Member of the German Center for Lung Research DZL,Translational Lung Research Center Heidelberg TLRCH
[3] Institute of Medical Biometry,University Hospital of Heidelberg
[4] Translational Research Unit (STF),Thoraxklinik at University Hospital of Heidelberg
[5] Diagnostic and Interventional Radiology with Nuclear Medicine,Thoraxklinik at University Hospital of Heidelberg
[6] Pneumology and Respiratory Care Medicine,Thoraxklinik at University Hospital of Heidelberg, Center for Interstitial and Rare Lung Diseases
[7] Institute of Clinical Cancer Research IKF GmbH at Northwest Hospital,Department of Radiation Oncology
[8] University Medical Center Göttingen,undefined
来源：
BMC Cancer | / 22卷
关键词：
Extensive disease small cell lung cancer; SCLC; Radioimmuntherapy; Thoracic radiotherapy; Atezolizumab; Anti-PD-L1 monoclonal antibody; First-line therapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399
    Gentzler, Ryan D.
    Villaruz, Liza C.
    Rhee, John C.
    Horton, Bethany
    Mock, Joseph
    Hanley, Michael
    Kim, Kyeongmin
    Rudek, Michelle A.
    Phelps, Mitch A.
    Carducci, Michael A.
    Piekarz, Richard
    Park, Kwon-Sik
    Bullock, Timothy N.
    Rudin, Charles M.
    ONCOLOGIST, 2023, : E1007 - E1107
  • [42] Safety and patient-reported outcomes of atezolizumab, carboplatin, and etoposide in extensive-stage small-cell lung cancer (IMpower133): a randomized phase I/III trial
    Mansfield, A. S.
    Kazarnowicz, A.
    Karaseva, N.
    Sanchez, A.
    De Boer, R.
    Andric, Z.
    Reck, M.
    Atagi, S.
    Lee, J-S
    Garassino, M.
    Liu, S., V
    Horn, L.
    Wen, X.
    Quach, C.
    Yu, W.
    Kabbinavar, F.
    Lam, S.
    Morris, S.
    Califano, R.
    ANNALS OF ONCOLOGY, 2020, 31 (02) : 310 - 317
  • [43] A German multicenter, randomized phase III trial comparing irinotecan-carboplatin with etoposide-carboplatin as first-line therapy for extensive-disease small-cell lung cancer
    Schmittel, A.
    Sebastian, M.
    von Weikersthal, L. Fischer
    Martus, P.
    Gauler, T. C.
    Kaufmann, C.
    Hortig, P.
    Fischer, J. R.
    Link, H.
    Binder, D.
    Fischer, B.
    Caca, K.
    Eberhardt, W. E. E.
    Keilholz, U.
    ANNALS OF ONCOLOGY, 2011, 22 (08) : 1798 - 1804
  • [44] The efficacy of thoracic radiotherapy in extensive stage small cell lung cancer with baseline brain metastases: a multi-institutional retrospective cohort study
    Zheng, Zhiqin
    Yuan, Xun
    Zhou, Yue
    Chu, Li
    Yang, Xi
    Ni, Jianjiao
    Chu, Qian
    Chu, Xiao
    Liu, Yanfei
    Zhu, Zhengfei
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [45] Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial
    Bria, Emilio
    Morgillo, Floriana
    Garassino, Marina Chiara
    Ciardiello, Fortunato
    Ardizzoni, Andrea
    Stefani, Alessio
    Verderame, Francesco
    Morabito, Alessandro
    Chella, Antonio
    Tonini, Giuseppe
    Gilli, Marina
    Del Signore, Ester
    Berardi, Rossana
    Mencoboni, Manlio
    Bearz, Alessandra
    Delmonte, Angelo
    Migliorino, Marta Rita
    Gridelli, Cesare
    Pazzola, Antonio
    Iero, Manuela
    De Marinis, Filippo
    ONCOLOGIST, 2024, : e690 - e698
  • [46] Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I–II study
    C Tibaldi
    T Prochilo
    F Russo
    M C Pennucci
    A Del Freo
    F Innocenti
    A Fabbri
    A Falcone
    P F Conte
    E Baldini
    British Journal of Cancer, 2006, 94 : 1263 - 1266
  • [47] Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group
    Costa Rivas, M.
    Huidobro Vence, G.
    Firvida Perez, J. L.
    Campos Balea, B.
    Garcia Gonzalez, J.
    Lazaro Quintela, M.
    Caeiro Munoz, M.
    Taboada Valladares, B.
    Castro Gomez, J. E.
    Vazquez Estevez, S.
    Afonso Afonso, F. J.
    Azpitarte Raposeiras, C.
    Amenedo Gancedo, M.
    Casal Rubio, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (11) : 1467 - 1473
  • [48] Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group
    M. Costa Rivas
    G. Huidobro Vence
    J. L. Fírvida Pérez
    B. Campos Balea
    J. García Gonzalez
    M. Lázaro Quintela
    M. Caeiro Muñoz
    B. Taboada Valladares
    J. E. Castro Gómez
    S. Vázquez Estevez
    F. J. Afonso Afonso
    C. Azpitarte Raposeiras
    M. Amenedo Gancedo
    J. Casal Rubio
    Clinical and Translational Oncology, 2018, 20 : 1467 - 1473
  • [49] Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer†
    Sun, J. -M.
    Ahn, Y. C.
    Choi, E. K.
    Ahn, M. -J.
    Ahn, J. S.
    Lee, S. -H.
    Lee, D. H.
    Pyo, H.
    Song, S. Y.
    Jung, S. -H.
    Jo, J. S.
    Jo, J.
    Sohn, H. J.
    Suh, C.
    Lee, J. S.
    Kim, S. -W.
    Park, K.
    ANNALS OF ONCOLOGY, 2013, 24 (08) : 2088 - 2092
  • [50] Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study
    Barlesi, Fabrice
    Vansteenkiste, Johan
    Spigel, David
    Ishii, Hidenobu
    Garassino, Marina
    de Marinis, Filippo
    Ozguroglu, Mustafa
    Szczesna, Aleksandra
    Polychronis, Andreas
    Uslu, Ruchan
    Krzakowski, Maciej
    Lee, Jong-Seok
    Calabro, Luana
    Frontera, Osvaldo Aren
    Ellers-Lenz, Barbara
    Bajars, Marcis
    Ruisi, Mary
    Park, Keunchil
    LANCET ONCOLOGY, 2018, 19 (11) : 1468 - 1479
12345